@dpastoors.bsky.social gave nice talk on p300&CBP regulating enhancer activity in AML which was awarded with the Best Presentation Award! 🤩🥳
#Hemesky
@dpastoors.bsky.social gave nice talk on p300&CBP regulating enhancer activity in AML which was awarded with the Best Presentation Award! 🤩🥳
#Hemesky
In this work we describe DNMT3A double mutant AML as an unique subtype with a poor prognosis and high levels of methylation damage.
👇
ashpublications.org/bloodadvance...
In this work we describe DNMT3A double mutant AML as an unique subtype with a poor prognosis and high levels of methylation damage.
👇
ashpublications.org/bloodadvance...